These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 19667570)

  • 1. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of clinical guidelines.
    Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice.
    Perfetto EM; Gondek K
    Manag Care Interface; 2002 Jun; 15(6):35-42. PubMed ID: 12087605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
    CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India.
    Vignesh R; Shankar EM; Murugavel KG; Kumarasamy N; Sekar R; Irene P; Solomon S; Balakrishnan P
    Nephron Clin Pract; 2008; 110(1):c55-7. PubMed ID: 18724067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
    Le TP; Miller LG
    Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
    Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
    J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Sandel DC; Wang CT; Kessler S
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11844861
    [No Abstract]   [Full Text] [Related]  

  • 19. Empirical treatment of urinary tract infections.
    Leibovici L
    Isr Med Assoc J; 2000 Oct; 2(10):804-5. PubMed ID: 11344744
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.